Antisoma to present at Canaccord Global Growth Conference

 
TIDMASM 
 
6 August 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: 
ATSMY) announces that senior executive Dr Michael Boss will present at the 30th 
Annual Canaccord Global Growth Conference in Boston on Wednesday August 11 at 
1pm local time (6pm BST). 
 
A webcast of the presentation will be available on Antisoma's website 
athttp://www.antisoma.com/asm/media/webcast/ 
 
For live viewing of the webcast, it is recommended that viewers log on 15 
minutes early in order to register and download any necessary software. 
 
Enquiries: 
Alison Saville 
Senior Marketing and Communications Executive 
Antisoma plc 
[phone] 
 
Background on Antisoma 
Antisoma is a London Stock Exchange-listed biopharmaceutical company that 
develops novel products for the treatment of cancer. The Company has operations 
in the UK and the US. Please visitwww.antisoma.com for further information about 
Antisoma. 
 
 
 
[HUG#1436343] 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
All reproduction for further distribution is prohibited. 
 
Source: Antisoma plc via Thomson Reuters ONE